Physicians shares insights about screening, supportive care and potential therapies in development
Focus is exocrine pancreatic stem cell development
New findings about the drug’s safety and efficacy from a phase II trial
Seth Rotz, MD, joins the Cancer Advances podcast to share insights
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A 12-year-old patient and others in clinical trial are cured of sickle cell disease thanks to half-match donors
Combination therapy shows promise in pediatric patient population
What pediatric cancer centers can do to improve access to patients
Key findings from national database study
Recommendations reflect weak evidence, unnecessary risks or high costs
Slight deviation from treatment paradigm salvages significant anatomy
Advertisement
Advertisement